Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Personalis, Inc.PSNL · Entity 4572 | Director · Chief Executive Officer | September 18, 2026 | September 22, 2026 |
| VERACYTE, INC.VCYT · Entity 2018 | President and COO | June 03, 2019 | June 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Personalis, Inc.
Report date September 18, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 228,527 |
Reported balance
After 2026-09-18 transaction · row 1
1 source rowRow 1 · 2026-09-18 · Sale · Disposed 7,459 · Balance 228,527 F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
VERACYTE, INC.
Report date June 03, 2019 · Filed June 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,258 |
Reported balance
After 2019-06-03 transaction · row 1
1 source rowRow 1 · 2019-06-03 · Tax withholding · Disposed 456 · Balance 28,258 F1: The reporting person is reporting the withholding of 456 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 918 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of 456 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 918 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 18, 2026 Filed Sep 22, 2026 20:10 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 7,459 | $16.22 | $120,984.98 |
DisclosureSEC source: 0001449535-26-000008 · form4-09222026_040904.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,527 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| July 09, 2026 Filed Jul 10, 2026 00:46 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (right to buy) · Derivative | 33,333 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001449535-26-000006 · form4-07102026_120749.xml · derivative · entry 4 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,333 shares Expires 2034-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| July 09, 2026 Filed Jul 10, 2026 00:46 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (right to buy) · Derivative | 66,667 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001449535-26-000006 · form4-07102026_120749.xml · derivative · entry 3 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,333 Underlying: Common Stock · 66,667 shares Expires 2034-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. F3 · derivative.exercise_date: The option vested and became exercisable over the three-year period commencing April 15, 2024, with 1/36th of the shares subject to the option vesting each month of continuous service thereafter. Read SEC document |
| July 09, 2026 Filed Jul 10, 2026 00:46 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 100,000 | $15.08 | $1,508,000.00 |
DisclosureSEC source: 0001449535-26-000006 · form4-07102026_120749.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 235,986 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $15.00 to $15.24 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 09, 2026 Filed Jul 10, 2026 00:46 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 100,000 | $1.61 | $161,000.00 |
DisclosureSEC source: 0001449535-26-000006 · form4-07102026_120749.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 335,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. Read SEC document |
| June 26, 2026 Filed Jun 26, 2026 23:49 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001449535-26-000004 · form4-06262026_110649.xml · derivative · entry 3 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 100,000 shares Expires 2034-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. F3 · derivative.exercise_date: The option vested and became exercisable over the three-year period commencing April 15, 2024, with 1/36th of the shares subject to the option vesting each month of continuous service thereafter. Read SEC document |
| June 26, 2026 Filed Jun 26, 2026 23:49 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 100,000 | $13.15 | $1,315,000.00 |
DisclosureSEC source: 0001449535-26-000004 · form4-06262026_110649.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 235,986 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $13.00 to $13.36 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 26, 2026 Filed Jun 26, 2026 23:49 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 100,000 | $1.61 | $161,000.00 |
DisclosureSEC source: 0001449535-26-000004 · form4-06262026_110649.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 335,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. Read SEC document |
| May 29, 2026 Filed May 30, 2026 00:45 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (right to buy) · Derivative | 80,091 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001449535-26-000003 · form4-05292026_080501.xml · derivative · entry 6 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 80,091 shares Expires 2034-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. F4 · derivative.exercise_date: The option vested and became exercisable over the three-year period commencing April 15, 2024, with 1/36th of the shares subject to the option vesting each month of continuous service thereafter. Read SEC document |
| May 29, 2026 Filed May 30, 2026 00:45 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 80,091 | $11.02 | $882,602.82 |
DisclosureSEC source: 0001449535-26-000003 · form4-05292026_080501.xml · nonDerivative · entry 4 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 235,986 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. F3 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $11.00 to $11.12 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 29, 2026 Filed May 30, 2026 00:45 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 80,091 | $1.61 | $128,946.51 |
DisclosureSEC source: 0001449535-26-000003 · form4-05292026_080501.xml · nonDerivative · entry 3 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 316,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. Read SEC document |
| May 28, 2026 Filed May 30, 2026 00:45 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (right to buy) · Derivative | 19,909 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001449535-26-000003 · form4-05292026_080501.xml · derivative · entry 5 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 380,091 Underlying: Common Stock · 19,909 shares Expires 2034-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. F4 · derivative.exercise_date: The option vested and became exercisable over the three-year period commencing April 15, 2024, with 1/36th of the shares subject to the option vesting each month of continuous service thereafter. Read SEC document |
| May 28, 2026 Filed May 30, 2026 00:45 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 19,909 | $11.02 | $219,397.18 |
DisclosureSEC source: 0001449535-26-000003 · form4-05292026_080501.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 235,986 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $11.00 to $11.05 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 28, 2026 Filed May 30, 2026 00:45 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 19,909 | $1.61 | $32,053.49 |
DisclosureSEC source: 0001449535-26-000003 · form4-05292026_080501.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 255,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:55 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 525,000 | $0.00 Strike: $6.72 | $0.00 |
DisclosureSEC source: 0001449535-26-000002 · form4-03172026_080326.xml · derivative · entry 2 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 525,000 Underlying: Common Stock · 525,000 shares Expires 2036-03-15 F2 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:55 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantCommon Stock | 87,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001449535-26-000002 · form4-03172026_080326.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,986 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 6 equal semi-annual installments with the first installment vesting on September 15, 2026. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 23:47 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 33,333 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001449535-26-000001 · form4-02252026_110220.xml · derivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 33,333 shares Expires 2034-03-15 F1 · balance_after: This amount represents the vesting of a performance stock option granted on March 15, 2024, following the satisfaction of a specified reimbursement milestone. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:05 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 29,612 | $8.99 | $266,211.88 |
DisclosureSEC source: 0001449535-25-000004 · form4-11052025_041103.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,486 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $8.78 to $9.56 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:44 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 680,000 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001415889-25-008427 · form4-03182025_080340.xml · derivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 680,000 Underlying: Common Stock · 680,000 shares Expires 2035-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2025. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:15 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 26,443 | $5.38 | $142,263.34 |
DisclosureSEC source: 0001415889-24-026124 · form4-11052024_041104.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,098 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $5.05 to $5.58 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:30 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-008533 · form4-03192024_040327.xml · derivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2024. Read SEC document |
| November 01, 2023 Filed Nov 4, 2023 01:00 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 20,459 | $0.93 | $19,026.87 |
DisclosureSEC source: 0001209191-23-054435 · doc4.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,541 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 22:08 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001209191-23-019860 · doc4.xml · derivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2033-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2023. Read SEC document |
| June 03, 2019 Filed Jun 5, 2019 20:23 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 456 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000060 · wf-form4_155976622460250.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,258 F1 · shares: The reporting person is reporting the withholding of 456 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 918 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 8,506 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · derivative · entry 8 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,688 Underlying: Common Stock · 8,506 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F6 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 63,746 | $0.00 Strike: $6.45 | $0.00 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · derivative · entry 7 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,254 Underlying: Common Stock · 63,746 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 42,748 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · derivative · entry 6 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,252 Underlying: Common Stock · 42,748 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 86,220 | $25.44 | $2,193,272.98 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · nonDerivative · entry 5 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,714 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.00 to $25.82. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 28,780 | $24.72 | $711,441.60 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · nonDerivative · entry 4 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,934 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $24.00 to $24.98. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,506 | $5.98 | $50,865.88 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · nonDerivative · entry 3 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 63,746 | $6.45 | $411,161.70 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 42,748 | $8.86 | $378,747.28 |
DisclosureSEC source: 0001384101-19-000054 · wf-form4_155734740865962.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 20:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 19,056 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · derivative · entry 8 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,194 Underlying: Common Stock · 19,056 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 20:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 43,017 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · derivative · entry 7 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,017 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 20:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 17,927 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · derivative · entry 6 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,927 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 20:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 4,836 | $25.58 | $123,698.59 |
DisclosureSEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · nonDerivative · entry 5 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,714 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $25.55 to $25.60. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 20:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 75,164 | $25.09 | $1,885,985.02 |
DisclosureSEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · nonDerivative · entry 4 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,550 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $24.55 to $25.54. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 20:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 19,056 | $5.98 | $113,954.88 |
DisclosureSEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · nonDerivative · entry 3 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 20:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 43,017 | $4.00 | $172,068.00 |
DisclosureSEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 20:51 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 17,927 | $2.68 | $48,044.36 |
DisclosureSEC source: 0001384101-19-000036 · wf-form4_155510225985847.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 12, 2019. Read SEC document |
| March 03, 2019 Filed Mar 4, 2019 23:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000018 · wf-form4_155174356261401.xml · nonDerivative · entry 2 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,714 F2 · shares: The reporting person is reporting the withholding of 2,282 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 6,667 Restricted Stock Units granted on March 3, 2017. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4. Read SEC document |
| March 02, 2019 Filed Mar 4, 2019 23:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 1,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-19-000018 · wf-form4_155174356261401.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,996 F1 · shares: The reporting person is reporting the withholding of 1,459 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 3,675 Restricted Stock Units granted on March 2, 2018. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 19,573 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-18-000080 · wf-form4_154110641114738.xml · derivative · entry 10 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 813 Underlying: Common Stock · 19,573 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F5 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 16,927 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001384101-18-000080 · wf-form4_154110641114738.xml · derivative · entry 9 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,927 shares Expires 2022-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F4 · derivative.exercise_date: The option became exercisable upon the grant date. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001384101-18-000080 · wf-form4_154110641114738.xml · derivative · entry 8 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500 shares Expires 2021-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F4 · derivative.exercise_date: The option became exercisable upon the grant date. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 19,573 | $14.00 | $274,022.00 |
DisclosureSEC source: 0001384101-18-000080 · wf-form4_154110641114738.xml · nonDerivative · entry 7 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 19,573 | $2.68 | $52,455.64 |
DisclosureSEC source: 0001384101-18-000080 · wf-form4_154110641114738.xml · nonDerivative · entry 6 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 427 | $14.00 | $5,978.00 |
DisclosureSEC source: 0001384101-18-000080 · wf-form4_154110641114738.xml · nonDerivative · entry 5 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 16,500 | $13.02 | $214,770.60 |
DisclosureSEC source: 0001384101-18-000080 · wf-form4_154110641114738.xml · nonDerivative · entry 4 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,882 F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $13.00 to $13.08. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 21:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 16,927 | $2.68 | $45,364.36 |
DisclosureSEC source: 0001384101-18-000080 · wf-form4_154110641114738.xml · nonDerivative · entry 3 Hall Christopher M · CIK 0001449535 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.